drugset / Trial / NCT00388609
Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to learn if BMS-646256 can cause weight loss in men and women who are: * overweight with high blood pressure or high cholesterol or * obese The safety of this treatment will also be studied
Timeline
- Start
- 2006-11
- Primary completion
- 2007-09
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ibipinabant | Small molecule | 50 mg | — |